Saturday 17 October 2026 Export NRIX’s income statement to Excel — free account

Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc.’s revenue for fiscal 2025 (year ended November 2025) was $84.0 million, up 54.0% from fiscal 2024. In the quarter to August 2026, revenue grew 8,426.3%, EPS grew 578.5% and free cash flow grew 1,122.1%, each against the same quarter a year earlier.

24.42 0.53 −2.12%

Follow NRIX

Alert me

Market cap: $2.7B
P/E: 9.7×
Fwd P/E: −4.9×
Dividend yield: —
F-score: 4/9
Altman Z: 3.77
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Aug '26	May '26	Feb '26	Nov '25	Older periods
Piotroski F-Score Full definition →	7	2	2	4	+8 more TTM periods Free account
ROE Full definition →	43.99%	(80.30%)	(61.40%)	(49.63%)
ROA Full definition →	34.33%	(60.57%)	(47.20%)	(38.96%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	29.71%	(84.40%)	(61.02%)	(48.72%)
Average Days of Receivables Full definition →	10.40	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	3.31	(2.74)	(2.47)	(3.04)
Free Cash Flow Full definition →	369.81	(304.53)	(271.85)	(263.47)
Capital Expenditures Full definition →	(9.50)	(10.82)	(11.56)	(14.00)
Other line items
Cash ROIC Full definition →	18.34%	(35.99%)	(26.61%)	(23.28%)
Accounts Receivable Turnover Full definition →	66.22	0.00	0.00	0.00
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	(0.05)	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	47.59%	927.31%	461.66%	377.36%
Selling, General and Administrative Expense of Revenue Full definition →	11.14%	155.06%	77.60%	62.80%
Share Based Compensation of Revenue Full definition →	5.79%	107.84%	53.84%	45.21%
Operating CF/Net income Full definition →	1.29	0.86	0.88	0.94
Depreciation/Fixed assets Full definition →	0.29	0.35	0.38	0.38
Capex/Depreciation Full definition →	(1.71)	(1.56)	(1.41)	(1.64)
Revenue per Share Full definition →	6.29	0.33	0.65	0.97
Operating CF per Share Full definition →	3.40	(2.64)	(2.36)	(2.88)
Capex per Share Full definition →	(0.09)	(0.10)	(0.10)	(0.16)
Capex to Sales Full definition →	0.01	0.29	0.16	0.17

Show all line items

Columns are period end dates · fundamentals updated 15 Oct 2026

Stockrow Weekly